Sophia Lin
3650 Gilmore Way
Burnaby, BC V5G4W8, Canada
Burnaby, BC V5G4W8, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Discovery of novel cyclopentane carboxylic acids as potent and selective inhibitors of NaV1.7.
Journal: Bioorganic & medicinal chemistry letters
Published: September 20, 2024
The contribution of NaV1.6 to the efficacy of voltage-gated sodium channel inhibitors in wild type and NaV1.6 gain-of-function (GOF) mouse seizure control.
Journal: British journal of pharmacology
Published: December 21, 2023
Development and application of a multiple reaction monitoring method for the simultaneous quantification of sodium channels Nav 1.1, Nav 1.2, and Nav 1.6 in solubilized membrane proteins from stable HEK293 cell lines, rodents, and human brain tissues.
Journal: Rapid communications in mass spectrometry : RCM
Published: June 28, 2023
Structure-function relationship of new peptides activating human Nav1.1.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 23, 2023
Potent, Gut-Restricted Inhibitors of Divalent Metal Transporter 1: Preclinical Efficacy against Iron Overload and Safety Evaluation.
Journal: The Journal of pharmacology and experimental therapeutics
Published: September 01, 2022
Pharmacological determination of the fractional block of Nav channels required to impair neuronal excitability and ex vivo seizures.
Journal: Frontiers in cellular neuroscience
Published: June 09, 2022
Synthetic Analogues of Huwentoxin-IV Spider Peptide With Altered Human NaV1.7/NaV1.6 Selectivity Ratios.
Journal: Frontiers in cell and developmental biology
Published: October 20, 2021
Identification of aryl sulfonamides as novel and potent inhibitors of NaV1.5.
Journal: Bioorganic & medicinal chemistry letters
Published: April 07, 2021
Discovery of Acyl-sulfonamide Nav1.7 Inhibitors GDC-0276 and GDC-0310.
Journal: Journal of medicinal chemistry
Published: March 08, 2021
Identification of CNS-Penetrant Aryl Sulfonamides as Isoform-Selective NaV1.6 Inhibitors with Efficacy in Mouse Models of Epilepsy.
Journal: Journal of medicinal chemistry
Published: September 19, 2019
Structure- and Ligand-Based Discovery of Chromane Arylsulfonamide Nav1.7 Inhibitors for the Treatment of Chronic Pain.
Journal: Journal of medicinal chemistry
Published: April 04, 2019
Last Updated: 09/26/2026